- Home
- JWN vs AXSM Comparison
JWN vs AXSM Comparison
Compare JWN & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JWN
- AXSM
- Stock Information
- Founded
- JWN 1901
- AXSM 2012
- Country
- JWN United States
- AXSM United States
- Employees
- JWN N/A
- AXSM N/A
- Industry
- JWN Clothing/Shoe/Accessory Stores
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- JWN Consumer Discretionary
- AXSM Health Care
- Exchange
- JWN Nasdaq
- AXSM Nasdaq
- Market Cap
- JWN 3.8B
- AXSM 4.0B
- IPO Year
- JWN N/A
- AXSM 2015
- Fundamental
- Price
- JWN $22.24
- AXSM $92.69
- Analyst Decision
- JWN Hold
- AXSM Strong Buy
- Analyst Count
- JWN 14
- AXSM 14
- Target Price
- JWN $20.07
- AXSM $124.57
- AVG Volume (30 Days)
- JWN 3.1M
- AXSM 416.4K
- Earning Date
- JWN 08-27-2024
- AXSM 11-04-2024
- Dividend Yield
- JWN 3.42%
- AXSM N/A
- EPS Growth
- JWN 804.21
- AXSM N/A
- EPS
- JWN 1.70
- AXSM N/A
- Revenue
- JWN $14,969,000,000.00
- AXSM $291,489,000.00
- Revenue This Year
- JWN $1.95
- AXSM $42.50
- Revenue Next Year
- JWN $1.87
- AXSM $69.28
- P/E Ratio
- JWN $13.04
- AXSM N/A
- Revenue Growth
- JWN 1.02
- AXSM 59.73
- 52 Week Low
- JWN $12.88
- AXSM $55.02
- 52 Week High
- JWN $24.03
- AXSM $98.40
- Technical
- Relative Strength Index (RSI)
- JWN 51.21
- AXSM 61.23
- Support Level
- JWN $21.84
- AXSM $91.52
- Resistance Level
- JWN $23.58
- AXSM $96.56
- Average True Range (ATR)
- JWN 0.80
- AXSM 2.83
- MACD
- JWN 0.05
- AXSM 0.36
- Stochastic Oscillator
- JWN 49.44
- AXSM 59.91
About JWN Nordstrom Inc.
Nordstrom is a fashion retailer that operates about 93 department stores and approximately 260 off-price Nordstrom Rack stores. The company also operates both full- and off-price e-commerce sites, two clearance stores, and seven Local locations. Nordstrom's largest merchandise categories are women's apparel (27% of 2023 sales), shoes (26% of 2023 sales), men's apparel (15% of 2023 sales), and beauty (13% of 2023 sales). Nordstrom, which traces its history to a shoe store opened in Seattle in 1901, continues to be partially owned and managed by members of the eponymous family.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.